Research Partnership has published a new patient Living with Diabetes (LATAM) 2018 report
Living with Diabetes is a report based on a new study conducted amongst approximately 116 Type 2 (T2D) diabetes patients in Brazil and 105 patients in Mexico. The report consists of 30-minute quantitative online and qualitative telephone interviews with T2D patients. US and EU reports are planned to launch in 2019.
Research Partnership launches new patient Living with Diabetes (LATAM) 2018 report
Living with Diabetes is a study conducted amongst approximately 200 Type 2 (T2D) diabetes patients in Brazil and Mexico. The report will consist of quantitative 30-minute online and qualitative telephone interviews with T2D patients. Results will be available to purchase October 2018.
Heather Desmet appointed new Head of Living With
We are delighted to welcome Heather Desmet as Head of Living With at the company’s London headquarters.
Heather joins us from an gency specialising in large scale syndicated research projects within the Southern African healthcare sector. Heather brings with her more than 10 years of experience in a wide variety of qualitative and quantitative methodologies, utilised across the private and public healthcare sectors. She has extensive experience in market understanding, communications, patient and provider positioning research and project management.
Could ‘around the pill’ solutions be the key to effective diabetes management?
Published in pharmaphorum July 2015 by Julie Denny
Research with patients shows that they have particular needs at specific stages, from diagnosis to longer-term disease management, that pharma and technology could address.
In the crowded type 2 diabetes market, pharma companies need to find other ways, beyond blood glucose control, to differentiate their brands. In an effort to stand out, players such as Janssen have developed 'around the pill' support programmes that aim to help patients address the health and lifestyle issues which are causing them to struggle to maintain management of their disease.
Uncovering hidden insights into patient compliance
Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment regimen. But assessing compliance can be difficult with traditional methods giving biased results. Would the use of digital techniques elicit greater insights?